Vision health perspectives on Breaking Bad: Ophthalmic sequelae of methamphetamine use disorder
Frontiers in Toxicology, ISSN: 2673-3080, Vol: 5, Page: 1135792
2023
- 2Citations
- 7Captures
- 1Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations2
- Citation Indexes2
- Captures7
- Readers7
- Mentions1
- News Mentions1
- 1
Most Recent News
Reports Outline Central Nervous System Agents Research from University of Nebraska Medical Center (Vision health perspectives on Breaking Bad: Ophthalmic sequelae of methamphetamine use disorder)
2023 MAR 20 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Drug Daily -- New study results on central nervous system agents have
Article Description
Methamphetamine use has become a rampant public health issue that not only causes devastating consequences to the user but also poses a burden to surrounding communities. A spectrum of ophthalmic sequelae is associated with methamphetamine use and includes episcleritis, scleritis, corneal ulceration, panophthalmitis, endophthalmitis, retinal vasculitis, and retinopathy. In many instances, prompt recognition of the condition and associated infectious process and early initiation of antimicrobial therapy are crucial steps to preventing vision loss. In this review, we summarize the reported ocular complications that may result from methamphetamine use in addition to several postulated mechanisms regarding the ocular toxicity of methamphetamine. The increasing prevalence of methamphetamine use as a public health threat highlights the need for continued investigation of this ophthalmologic issue.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85159887921&origin=inward; http://dx.doi.org/10.3389/ftox.2023.1135792; http://www.ncbi.nlm.nih.gov/pubmed/36969265; https://www.frontiersin.org/articles/10.3389/ftox.2023.1135792/full; https://dx.doi.org/10.3389/ftox.2023.1135792; https://www.frontiersin.org/journals/toxicology/articles/10.3389/ftox.2023.1135792/full
Frontiers Media SA
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know